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More meat, milk and fish—by and for the poor
Animal health component: Background 
proposals for the CGIAR Research Program 
on Livestock and Fish
Interventions aimed at controlling or preventing animal diseases can improve productivity by decreasing 
mortality and morbidity. The key interventions on which we shall focus to improve animal health are vaccines 
and diagnostics for livestock and improved biosecurity for fish hatcheries. In these areas, opportunities exist for 
immediate impact by modifying current interventions to make them more suitable for poor livestock owners, 
e.g. thermostable vaccines and rapid field diagnostics, as well as for longer-term research for more intractable 
problems.
Vaccines are particularly suited to poor livestock farming systems as they are often cheap and can offer a 
sustainable means of disease control by providing life-long protection. Vaccines have the power to eradicate 
diseases, as has been shown with smallpox and rinderpest, viral diseases of humans and animals, respectively. 
Diagnostic tools play a critical role in establishing the geographical extent of diseases, in vaccine development 
by elucidating pathogen variability, in underpinning disease control strategies such as movement restriction, in 
facilitating trade and in disease surveillance and pathogen discovery. The implementation of improved hygiene 
and biosecurity measures can have major effects in limiting the introduction and spread of livestock and fish 
diseases. For example, this is the case for the major diseases affecting aquaculture, where control is mediated 
by preventing the introduction of diseased seed stock rather than the elimination of extant diseases.
Our approach will consist of two interdependent activities. First, we shall examine each of the value chains 
and identify the constraints to productivity imposed by infectious diseases. This will involve disease mapping 
to identify the prevalent infections, an assessment of the magnitude of the constraint imposed by the disease 
and technology scanning to determine if suitable interventions exist or can be developed and applied. This will 
also include an analysis of current institutional arrangements for the manufacture and delivery of technological 
interventions and the social and gender implications of these to determine if these act as a constraint. There 
are social and gender implications to development and delivery of animal health services including vaccines 
(Fandamu et al. 2006; Homewood et al. 2006). For example, Homewood et al. (2006) found that uptake of the 
ITM (Infection and Treatment Method) vaccine against East Coast fever in Tanzania was strongly associated 
with a measure of wealth that included livestock numbers and economic security. Medium and poor pastoralist 
households found it hard or impossible to access the full benefits of the vaccine. The wealthiest households 
vaccinated on average 43% of their herd, compared to the poorer households who had vaccinated on average 
14% of their herd. In addition, the currently available vaccine is packaged as a 40-dose straw, which may be 
unsuitable for poor and women livestock keepers who often have smaller herds.
The second activity will build on current research activities to deliver practical solutions in already identified 
disease constraints. Where possible, emphasis will be placed on the development of ‘generic’ research 
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platforms within the context of a disease focus, so that the required expertise and equipment can be applied to 
research topics uncovered in the first component. It is acknowledged that rapid advances in the power of tools 
to understand basic biological processes can be applied to develop new and improved vaccines and diagnostic 
assays. These include genomics-based approaches to identify pathogen molecules for inclusion in new vaccines 
and diagnostic assays, to understand host responses to infectious disease, and to acquire greater knowledge of 
how pathogens evolve and how diseases are transmitted and spread. 
Envisaged outputs of these activities include novel vaccines and diagnostic assays for diseases that constrain 
productivity in the identified value chains, maps of disease prevalence, improved arrangements for the delivery 
of animal health interventions to poor livestock owners that have potential to reach women and marginal 
populations, and documented strategies and enhanced capacity for greater biosecurity to prevent disease 
incursions. The outcome will be greater access of poor producers to novel or improved animal health inputs 
and services that will improve their wellbeing and enhance the resilience of their livelihoods. To achieve this, 
it is essential that the program champions and assumes stewardship for the whole development chain, from the 
identification of areas of need through development, manufacture, implementation and impact assessment of 
these solutions. 
Activities
Assessment of disease constraints across value chains (with Theme 2): We shall use an integrated approach to 
identify where diseases impose a constraint to productivity and where achievable goals can be set to develop 
and deliver appropriate technological solutions. The approach will involve producers including women, animal 
health service providers, disease experts, policymakers and the private sector. The economic importance of any 
particular disease constraint will be weighed against the prospects for creating new institutional arrangements 
or vaccines and diagnostic tools, the time required for the implementation of the intervention and the potential 
for private sector involvement. The key questions for consideration in any value chain are:
What are the diseases which constrain productivity and by how much? •	
are key diseases well-recognized? °
do disease mapping tools exist?  °
are there diseases present which prevent the introduction of better breeds or species?  °
are there diseases which prevent access to other markets? °
Do vaccines or diagnostic assays offer a solution?•	
better delivery of current vaccines through non-technological advances (better distribution channels,  °
increased awareness, coordinated vaccination campaigns)
better delivery of current vaccines through technological advances (improved thermostability, cheaper  °
production, more relevant components in response to pathogen evolution)
what are the prospects for the development of new vaccines (what is limiting the effectiveness of current  °
vaccines, does immunity exist after natural infection, and what is known about the immune response)?
would better or more available diagnostic assays facilitate disease control through movement restriction  °
or by identifying animals for treatment or slaughter, or underpin vaccination programs?
Does improved biosecurity offer a solution?•	
can more stringent hygiene practices prevent the incursion of diseases °
can the establishment of disease-free zones improve the control of diseases and access to markets °
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Assessment of animal health policy and institutional constraints across value chains (with Theme 2): As a 
part of the value chain development in Theme 2, the priority animal health constraints will be identified. For 
animal health constraints for which there are existing technical interventions (vaccines, diagnostics, drugs and 
preventative/biosecurity measures) but which are not being used, analysis will be undertaken to determine the 
reasons for the lack of uptake. This will involve consultations with: 
livestock owners and farmers’ and women’s groups, to determine if there is a lack of awareness or access, or •	
if the solution is perceived as ineffective, harmful or too expensive 
manufacturers from the private and public sector, to assess their perception of the factors which influence •	
demand for the particular intervention
animal health workers, to gauge their reasons for not using or promoting the intervention and the presence •	
or absence of incentives
government authorities, to understand policy and institutional requirements which may be hindering uptake •	
of the intervention and what kind of enabling policies could be introduced or amended to promote uptake of 
the intervention
A comparative analysis of cases with successful uptake of similar interventions will provide insights into 
the factors influencing uptake, such as incentives for actors along the value chain. Each of the proposed 
interventions will be assessed to determine how they will fit into the policy and institutional landscape 
(again an integral part of the value chain assessment in Theme 2) and the potential for developing business 
development services to provide affordable, quality animal health services. The findings will be targeted at the 
different stakeholders with media and formats selected as being most appropriate and cost-effective for each 
audience in accordance with the Communication Strategy (p. 79). 
Studies will be undertaken to determine the level of adoption of animal health services among poor and women 
livestock keepers and the factors (economic, social, policy, institutional) driving the adoption and continued 
use of these services. In particular, we shall identify gender issues in the development and delivery of animal 
health interventions, focusing on constraints to access and use of current and proposed interventions by women 
and poor livestock keepers. We shall identify and develop interventions which are amenable to technology 
modifications or improvements in delivery systems and, with key partners, assess different delivery systems for 
their potential to increase access. 
Building on current projects
Technology platforms—livestock: The development of vaccines and diagnostic assays is underpinned by generic 
technology which can be applied to specific diseases. We are using such platforms in our current research 
activities and we shall apply these to new projects identified by value chain analysis, described above, while 
completing the projects already in progress. The platforms are described in the Tables below.
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Vaccine technology platforms
Platform Purpose Scientific disciplines involved
Antigen 
identification
To identify pathogen molecules which stimulate a protective 
immune response. These molecules can be:
     incorporated into subunit vaccines
     monitored in whole pathogen vaccines
     analysed to determine the variation within pathogen  
     species 
     used in quality assurance of vaccine production
Immunology
Microbiology
Protein chemistry
Recombinant DNA technology
Pathogen genetics/evolutionary biology
Genomics/bioinformatics
Vaccine 
formulation 
To develop vaccine formulations into which antigens are 
incorporated for inoculation. The formulations determine 
the type and magnitude of the immune response and can 
lengthen the time needed between booster vaccinations
Immunology
Protein chemistry
Adjuvant chemistry
Viral vector biology
Lyophilization To produce vaccines which are stable at room temperature 
for several months to years
Physical chemistry
Thermo-stabilizers
Diagnostic assay technology platforms
Platform Purpose Scientific disciplines involved
Analyte 
identification
To identify pathogen molecules, usually protein or DNA, 
which are incorporated into a diagnostic assay. These 
molecules are:
     unique to the target pathogen
     detectable in easily obtained samples from the host
Immunology
Microbiology
Protein chemistry
Recombinant DNA technology
Pathogen genetics/evolutionary biology
Genomics/bioinformatics
Diagnostic assay 
platforms
To facilitate analyte detection in routine laboratories or in 
the field. Commonly used technologies include:
ELISAs
Polymerase chain reactions
‘Pen-side’ tests, such as lateral flow devices
There is potential for use of mobile telephone technology 
to extend diagnostic capacity
Protein chemistry
Nucleic acid chemistry
Microfluidics
Additional activities exist in other key areas to facilitate the identification of disease constraints and the delivery 
of technological interventions. These are listed and described in the following Table. 
Building on current projects—livestock: The development of novel vaccines and diagnostic assays is a long-
standing component of ILRI’s research strategy. The current target diseases have been selected on the basis of 
their importance to poor livestock owners. For the most part, they are ‘orphan’ diseases, as they do not present 
a sufficiently attractive market opportunity for funding agencies and the private sector in developed countries.
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Identification of disease constraints and the delivery of technological interventions
Activity Purpose
Vaccine delivery To develop institutional arrangements to facilitate the delivery of vaccines through sustainable distribution 
channels to poor livestock owners. Issues which are addressed include:
      engaging manufacturers for products for which there is little commercial attraction
      assessing the advantages of private or government animal health services
      assessing delivery systems with high potential for reaching women , youth and marginalized  
      populations
      registration and regulatory compliance
Pathogen 
discovery and 
surveillance 
To monitor the introduction and spread of pathogens in target regions, and to understand how pathogens 
evolve. This area relies heavily on genetics and genomics technology to identify and characterize discrete 
populations of pathogens within a species, and contributes to the control of disease outbreaks and 
whether vaccine or diagnostic assays require modification
Biobanking To characterize and store biological specimens systematically and sustainably to allow use of the material 
in future research projects, possibly for currently unforeseen aims
Diagnostic 
laboratory 
strengthening
To ensure that national and regional laboratories can undertake necessary laboratory testing. Key factors 
here include:
      developing assays which can be routinely and sustainably performed
      ensuring that staff are trained in assay performance, sample collection and result reporting
      establishing laboratory networks
The reasons for this are varied and include their geographical distribution being restricted to the developing 
world and their being controlled or eradicated from the developed world using means which are not applicable 
to areas of poor infrastructure and regulatory control. While not all of the projects are relevant to the identified 
value chains, we shall continue to work on them in the near future to deliver the specific outputs. At the same 
time, it is clear that the technologies used in these projects will be needed to address the disease constraints 
identified in the value chain analysis. The Table below presents an analysis of current research activities with 
respect to identified value chains and technology platforms being employed. 
ILRI’s current animal health research and its relevance to target value chains
Disease Value chain Vaccine and diagnostic technology Supporting activities
East Coast fever Tanzanian dairy antigen identification 
vaccine formulation
vaccine delivery 
pathogen surveillance
Contagious bovine 
pleuro-pneumonia
antigen identification 
vaccine formulation 
analyte identification 
diagnostic platforms
vaccine delivery
African swine fever Uganda pigs analyte identification pathogen surveillance 
laboratory strengthening
Porcine cysticercosis Uganda pigs 
Vietnam pigs
analyte identification 
diagnostic platforms
Peste de petits ruminants Ethiopian small ruminants 
Mali small ruminants 
thermostability vaccine delivery 
Rift Valley fever Ethiopian small ruminants 
Mali small ruminants
diagnostic platforms 
vaccine trials
pathogen surveillance 
vaccine delivery
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Fish health: The incidence of disease and its impacts on the different stages of the Ugandan fish value chain is 
poorly understood. However, preliminary analysis of the tilapia and African catfish value chains suggest that 
disease is primarily an issue in hatcheries. This was confirmed during a recent visit to a commercial hatchery, 
where several diseases affecting African catfish were reported, including:
Ich, or white spot, caused by the parasite •	 Ichthyophthirius multifilis
Columnaris disease, caused by the bacterium •	 Flexibacter columnaris
Saprolgenia•	 , a fungus that affects eggs
It is anticipated that these and similar diseases will become more important as the fish industry grows and 
production methods intensify. Of particular concern are new diseases, such as Epizootic Ulcerative Syndrome 
(EUS). EUS has recently been transferred from Asia to the Zambezi system, with potentially significant impacts 
on fish, fisheries and those who depend on them for their livelihoods. The key to control of hatchery diseases 
is improved biosecurity—better hatchery management, especially hygiene, and more stringent screening and 
monitoring of seed stock. These activities must be underpinned by well-trained veterinarians and modern 
diagnostic laboratory capacity. We are already partnering with the FAO and the private sector in the region to 
improve biosecurity.
As in the livestock sector, we shall undertake a needs assessment to determine current and potential disease 
constraints and the capacity of the extant fish health services to address these issues. This will be followed by 
implementation of appropriate interventions. Access to the CGIAR disease platform offers tools to screen for and 
detect potential new pathogens will be invaluable. We envisage synergies with the pig value chain in Uganda.
Partners: The most appropriate and relevant partners will vary according to the animal health constraint/
solution; where possible existing partnerships will be built upon. The specific value chain analyses will identify 
the priority animal health issues, the solutions to overcome these, whether the solutions are available or require 
development, their limitations and any barriers/constraints to their implementation. Barriers, constraints and 
limitations could be primarily technological or policy/institutional in nature and each would require very 
different types of partners. For example, if a vaccine exists but is not widely used because it is ineffective or has 
undesirable side-effects, then partners with expertise on that disease/vaccine would be engaged with a view 
to developing and delivering an improved vaccine: these could come from national, regional or international 
universities, research organizations and veterinary services, or public or private vaccine manufacturers. A 
key partner for African initiatives is AU-IBAR. The NGO GALVmed, a global alliance which specializes in 
establishing and managing public–private partnerships to develop and make available vaccines and other 
animal health products for neglected livestock diseases, is likely to be another key partner. GALVmed has 
indicated an interest in aligning their priority diseases to have better fit with CRP3.7’s target value chains. 
ILRI has extensive experience of working with partners with expertise in the policy and institutional arena; for 
example, during research on the Kenya dairy sector, productive partnerships were developed with the Institute 
for Development Studies, UK. With regard to delivery of animal health services, partners might include NGOs 
with expertise in this area, such as FARM-Africa and VSF. In summary, key partners will be sought according to 
the nature of the proposed solution and the constraint which is being addressed. 
BecA Hub laboratory facilities: It is envisaged that many of the activities will be undertaken at the BecA Hub, 
Nairobi. This comprises state-of-the-art laboratories, equipment and large and small animal facilities to enable 
a wide range of biological experimentation to be conducted. These include facilities for tissue culture, serology 
and cellular immunology, genomics, bio-informatics and high-throughput sequencing. 
The outputs and their expected outcomes and impacts for the animal health technology development 
component are summarized in the Table below.
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Animal health technology development outputs, outcomes and impacts
Outputs Outcomes Impacts
Diseases which constrain productivity in target value 
chains identified and their relative impacts assessed 
Extent to which vaccines and diagnostic assays offer a 
solution assessed
Existing vaccine technology platforms focused on 
priority diseases of selected value chains
Existing diagnostic assay development platforms 
focused on priority diseases of selected value chains
Options for delivery of vaccines to poor and women 
livestock keepers in value chains developed
Gender issues around vaccine development and 
delivery identified and integrated into technology 
development and delivery for selected value chains
Pathogen evolution, introduction and spread in value 
chains monitored 
Capacity building for national and regional labs 
Extent to which improved biosecurity offers a solution 
assessed
Development of better systems to 
deliver existing and forthcoming 
vaccines 
Development of better vaccines 
and diagnostics targeted on priority 
diseases in selected value chains
Development of appropriate 
biosecurity systems
Development of delivery systems 
that increase access to animal 
health services to women livestock 
keepers, and poor smallholders
Improved systems and capacities 
for monitoring evolution, 
introduction and spread of 
pathogens
Better control and prevention 
of priority animal diseases 
in selected value chains 
contributes to increased 
productivity and production of 
animal source foods to enhance 
livelihoods and nutrition 
security of the poor
Reduction of disparities 
between men and women in 
the access to and use of animal 
health services, and in the 
productivity of livestock owned 
and managed by them
Important note: Full information on references is included in the Program proposal that can be downloaded 
from http://cgspace.cgiar.org/handle/10568/3248.
